 Benjamin Kopecky
Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrophages | 13 | 2026 | 1507 | 2.260 |
Why?
| | Graft Rejection | 7 | 2026 | 521 | 1.720 |
Why?
| | Heart Transplantation | 5 | 2026 | 680 | 1.680 |
Why?
| | Organ Transplantation | 3 | 2026 | 251 | 1.540 |
Why?
| | Ear, Inner | 5 | 2013 | 51 | 1.180 |
Why?
| | Allografts | 2 | 2026 | 152 | 1.090 |
Why?
| | Organ of Corti | 7 | 2013 | 14 | 1.090 |
Why?
| | Cell Communication | 2 | 2026 | 328 | 1.010 |
Why?
| | Stromal Cells | 1 | 2026 | 121 | 0.920 |
Why?
| | Coronary Vessels | 1 | 2026 | 246 | 0.820 |
Why?
| | Transplantation Tolerance | 1 | 2024 | 39 | 0.810 |
Why?
| | Vascular Remodeling | 1 | 2026 | 209 | 0.790 |
Why?
| | Single-Cell Analysis | 2 | 2026 | 362 | 0.790 |
Why?
| | Vascular Diseases | 1 | 2026 | 252 | 0.760 |
Why?
| | Coronary Artery Disease | 2 | 2026 | 749 | 0.740 |
Why?
| | Myocardium | 5 | 2025 | 934 | 0.690 |
Why?
| | Proto-Oncogene Proteins c-myc | 2 | 2013 | 167 | 0.670 |
Why?
| | Hair Cells, Auditory | 6 | 2013 | 45 | 0.660 |
Why?
| | Microscopy, Confocal | 4 | 2013 | 319 | 0.600 |
Why?
| | Transcriptome | 1 | 2026 | 1038 | 0.600 |
Why?
| | Precision Medicine | 1 | 2024 | 459 | 0.600 |
Why?
| | Monocytes | 5 | 2024 | 539 | 0.540 |
Why?
| | Cell Differentiation | 6 | 2024 | 2046 | 0.510 |
Why?
| | Mice | 23 | 2026 | 18329 | 0.500 |
Why?
| | Animals | 30 | 2026 | 38030 | 0.500 |
Why?
| | Lung Transplantation | 1 | 2020 | 332 | 0.480 |
Why?
| | Cochlea | 4 | 2013 | 73 | 0.470 |
Why?
| | Genes, myc | 2 | 2012 | 51 | 0.420 |
Why?
| | Interferon Type I | 2 | 2026 | 147 | 0.400 |
Why?
| | Hair Cells, Auditory, Inner | 2 | 2013 | 16 | 0.400 |
Why?
| | Ear | 3 | 2015 | 31 | 0.380 |
Why?
| | Calcium Channel Blockers | 1 | 2014 | 166 | 0.380 |
Why?
| | Neuroprotective Agents | 1 | 2014 | 147 | 0.370 |
Why?
| | Graft Survival | 2 | 2026 | 518 | 0.370 |
Why?
| | Gait Ataxia | 1 | 2012 | 4 | 0.360 |
Why?
| | Calcium Channels, T-Type | 1 | 2014 | 104 | 0.360 |
Why?
| | Mice, Inbred C57BL | 9 | 2026 | 5983 | 0.360 |
Why?
| | Regeneration | 2 | 2013 | 197 | 0.340 |
Why?
| | Vestibular Diseases | 1 | 2012 | 57 | 0.330 |
Why?
| | Epithelium | 2 | 2011 | 310 | 0.330 |
Why?
| | Nervous System Diseases | 1 | 2014 | 286 | 0.330 |
Why?
| | Vestibule, Labyrinth | 1 | 2012 | 91 | 0.320 |
Why?
| | Gene Deletion | 2 | 2011 | 391 | 0.320 |
Why?
| | Sensory Receptor Cells | 1 | 2011 | 98 | 0.310 |
Why?
| | Cerebellum | 1 | 2012 | 224 | 0.310 |
Why?
| | Signal Transduction | 5 | 2026 | 5216 | 0.290 |
Why?
| | Heart | 3 | 2023 | 626 | 0.290 |
Why?
| | Imaging, Three-Dimensional | 1 | 2012 | 583 | 0.280 |
Why?
| | Mice, Knockout | 7 | 2024 | 3124 | 0.270 |
Why?
| | Cell Proliferation | 2 | 2013 | 2507 | 0.270 |
Why?
| | Hair Cells, Auditory, Outer | 2 | 2020 | 8 | 0.270 |
Why?
| | Tissue Donors | 2 | 2022 | 420 | 0.260 |
Why?
| | Transplantation, Homologous | 2 | 2026 | 418 | 0.260 |
Why?
| | Homeostasis | 2 | 2023 | 642 | 0.260 |
Why?
| | Euthyroid Sick Syndromes | 1 | 2026 | 6 | 0.240 |
Why?
| | Neointima | 1 | 2026 | 18 | 0.240 |
Why?
| | Thyrotropin | 1 | 2026 | 120 | 0.230 |
Why?
| | Thyroid Gland | 1 | 2026 | 89 | 0.230 |
Why?
| | CD47 Antigen | 1 | 2025 | 42 | 0.220 |
Why?
| | Nitriles | 1 | 2026 | 207 | 0.220 |
Why?
| | Pyrazoles | 2 | 2026 | 517 | 0.220 |
Why?
| | Arginase | 1 | 2024 | 26 | 0.210 |
Why?
| | Positron-Emission Tomography | 2 | 2024 | 343 | 0.210 |
Why?
| | Humans | 24 | 2026 | 145474 | 0.210 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2025 | 140 | 0.210 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2026 | 270 | 0.210 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2024 | 66 | 0.200 |
Why?
| | In Situ Hybridization | 3 | 2013 | 318 | 0.200 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2026 | 449 | 0.200 |
Why?
| | Doxorubicin | 1 | 2025 | 401 | 0.190 |
Why?
| | Ventricular Remodeling | 2 | 2024 | 278 | 0.190 |
Why?
| | Disease Models, Animal | 4 | 2026 | 4560 | 0.190 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2024 | 143 | 0.190 |
Why?
| | Myocardial Reperfusion Injury | 2 | 2024 | 139 | 0.180 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2024 | 296 | 0.180 |
Why?
| | Adipose Tissue, White | 1 | 2022 | 43 | 0.180 |
Why?
| | Ventricular Function, Right | 1 | 2025 | 297 | 0.180 |
Why?
| | Pyrimidines | 1 | 2026 | 530 | 0.180 |
Why?
| | Cyclosporine | 1 | 2023 | 256 | 0.180 |
Why?
| | PAX2 Transcription Factor | 2 | 2013 | 8 | 0.180 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2025 | 248 | 0.180 |
Why?
| | Receptors, Cell Surface | 1 | 2024 | 372 | 0.180 |
Why?
| | Cardiomyopathies | 1 | 2025 | 335 | 0.170 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2022 | 119 | 0.170 |
Why?
| | Integrases | 2 | 2013 | 122 | 0.170 |
Why?
| | Immunity, Innate | 2 | 2024 | 835 | 0.170 |
Why?
| | Antigens, CD | 1 | 2024 | 558 | 0.160 |
Why?
| | Altitude | 1 | 2025 | 463 | 0.160 |
Why?
| | Macrophage Activation | 1 | 2021 | 181 | 0.160 |
Why?
| | Immunohistochemistry | 3 | 2013 | 1716 | 0.160 |
Why?
| | Atherosclerosis | 1 | 2024 | 409 | 0.160 |
Why?
| | LIM Domain Proteins | 1 | 2020 | 20 | 0.160 |
Why?
| | Hearing Loss | 3 | 2015 | 249 | 0.150 |
Why?
| | Myocardial Infarction | 2 | 2024 | 1210 | 0.150 |
Why?
| | LIM-Homeodomain Proteins | 1 | 2020 | 16 | 0.150 |
Why?
| | Chronic Disease | 1 | 2026 | 1808 | 0.150 |
Why?
| | Nerve Tissue Proteins | 3 | 2012 | 591 | 0.150 |
Why?
| | Gait | 2 | 2013 | 312 | 0.150 |
Why?
| | Immunosuppressive Agents | 1 | 2024 | 838 | 0.150 |
Why?
| | Fibroblasts | 1 | 2024 | 1025 | 0.140 |
Why?
| | Phenotype | 2 | 2024 | 3155 | 0.140 |
Why?
| | Antioxidants | 1 | 2022 | 550 | 0.140 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2021 | 356 | 0.140 |
Why?
| | Hypoxia | 1 | 2025 | 1199 | 0.130 |
Why?
| | Neovascularization, Physiologic | 1 | 2018 | 192 | 0.130 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2020 | 425 | 0.120 |
Why?
| | Hearing | 2 | 2015 | 133 | 0.120 |
Why?
| | Kidney Transplantation | 1 | 2022 | 712 | 0.110 |
Why?
| | Embryo, Mammalian | 2 | 2012 | 234 | 0.110 |
Why?
| | Morpholines | 1 | 2015 | 130 | 0.110 |
Why?
| | Gene Expression Regulation, Developmental | 4 | 2012 | 910 | 0.100 |
Why?
| | Myocytes, Cardiac | 1 | 2019 | 546 | 0.100 |
Why?
| | Hypertension, Pulmonary | 1 | 2025 | 1957 | 0.100 |
Why?
| | Male | 9 | 2026 | 72842 | 0.100 |
Why?
| | Cell Lineage | 2 | 2024 | 377 | 0.090 |
Why?
| | Vertebrates | 1 | 2013 | 63 | 0.090 |
Why?
| | Evoked Potentials, Auditory, Brain Stem | 1 | 2013 | 50 | 0.090 |
Why?
| | Receptors, CCR2 | 2 | 2024 | 39 | 0.090 |
Why?
| | Phenylurea Compounds | 1 | 2013 | 119 | 0.090 |
Why?
| | ErbB Receptors | 1 | 2015 | 635 | 0.090 |
Why?
| | Transcription Factors | 1 | 2020 | 1734 | 0.090 |
Why?
| | Acoustic Stimulation | 1 | 2013 | 333 | 0.090 |
Why?
| | Cochlear Duct | 1 | 2011 | 1 | 0.080 |
Why?
| | Heart Failure | 1 | 2024 | 2326 | 0.080 |
Why?
| | Morphogenesis | 1 | 2012 | 172 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 977 | 0.080 |
Why?
| | Genotype | 2 | 2013 | 1852 | 0.080 |
Why?
| | Organ Specificity | 1 | 2011 | 309 | 0.080 |
Why?
| | Mice, Mutant Strains | 2 | 2021 | 302 | 0.080 |
Why?
| | Gene Transfer Techniques | 1 | 2011 | 187 | 0.070 |
Why?
| | Biological Evolution | 1 | 2013 | 467 | 0.070 |
Why?
| | Cell Cycle | 1 | 2011 | 598 | 0.070 |
Why?
| | Neoplasms | 1 | 2023 | 2906 | 0.060 |
Why?
| | Quality of Life | 1 | 2020 | 3204 | 0.060 |
Why?
| | Stem Cell Transplantation | 1 | 2008 | 189 | 0.060 |
Why?
| | Computer Simulation | 1 | 2011 | 1003 | 0.060 |
Why?
| | Thyroid Function Tests | 1 | 2026 | 19 | 0.060 |
Why?
| | Stem Cells | 1 | 2011 | 628 | 0.060 |
Why?
| | Cardiovascular Diseases | 1 | 2018 | 2187 | 0.060 |
Why?
| | Triiodothyronine | 1 | 2026 | 54 | 0.060 |
Why?
| | Bone Morphogenetic Protein 4 | 2 | 2020 | 44 | 0.060 |
Why?
| | Thyroxine | 1 | 2026 | 66 | 0.060 |
Why?
| | Genetic Therapy | 1 | 2008 | 316 | 0.060 |
Why?
| | Female | 8 | 2026 | 78844 | 0.050 |
Why?
| | Epitope Mapping | 1 | 2024 | 61 | 0.050 |
Why?
| | Time Factors | 2 | 2013 | 7123 | 0.050 |
Why?
| | Endopeptidases | 1 | 2024 | 80 | 0.050 |
Why?
| | Copper Radioisotopes | 1 | 2024 | 4 | 0.050 |
Why?
| | Serine Endopeptidases | 1 | 2024 | 128 | 0.050 |
Why?
| | Antineoplastic Agents | 1 | 2015 | 2214 | 0.050 |
Why?
| | Cell Hypoxia | 1 | 2024 | 247 | 0.050 |
Why?
| | Altitude Sickness | 1 | 2025 | 141 | 0.050 |
Why?
| | Cell Adhesion Molecules | 1 | 2024 | 181 | 0.050 |
Why?
| | Tissue Distribution | 1 | 2024 | 335 | 0.050 |
Why?
| | Acclimatization | 1 | 2025 | 170 | 0.050 |
Why?
| | Azetidines | 1 | 2023 | 45 | 0.050 |
Why?
| | Radiopharmaceuticals | 1 | 2024 | 205 | 0.050 |
Why?
| | Myofibroblasts | 1 | 2024 | 148 | 0.050 |
Why?
| | Sequence Analysis, RNA | 1 | 2025 | 442 | 0.050 |
Why?
| | Mutation | 3 | 2021 | 4075 | 0.050 |
Why?
| | Starch | 1 | 2022 | 22 | 0.050 |
Why?
| | Antibodies, Neutralizing | 1 | 2025 | 340 | 0.050 |
Why?
| | Interleukin-1beta | 1 | 2024 | 389 | 0.050 |
Why?
| | Purines | 1 | 2023 | 187 | 0.050 |
Why?
| | Receptor, Angiotensin, Type 1 | 1 | 2022 | 25 | 0.040 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2023 | 153 | 0.040 |
Why?
| | Fibrosis | 1 | 2024 | 559 | 0.040 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2022 | 115 | 0.040 |
Why?
| | Troponin T | 1 | 2021 | 63 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2022 | 266 | 0.040 |
Why?
| | Adipocytes | 1 | 2022 | 223 | 0.040 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 229 | 0.040 |
Why?
| | Chromatin | 1 | 2024 | 553 | 0.040 |
Why?
| | Heart Ventricles | 1 | 2025 | 756 | 0.040 |
Why?
| | Sulfonamides | 1 | 2023 | 583 | 0.040 |
Why?
| | SOXB1 Transcription Factors | 1 | 2020 | 67 | 0.040 |
Why?
| | Fatty Acids | 1 | 2022 | 457 | 0.040 |
Why?
| | Sex Factors | 1 | 2025 | 2105 | 0.040 |
Why?
| | Molecular Imaging | 1 | 2019 | 57 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2023 | 734 | 0.040 |
Why?
| | Evolution, Molecular | 2 | 2013 | 492 | 0.030 |
Why?
| | Cell Survival | 2 | 2012 | 1100 | 0.030 |
Why?
| | Stroke Volume | 1 | 2022 | 654 | 0.030 |
Why?
| | Ventricular Function, Left | 1 | 2022 | 542 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2024 | 1164 | 0.030 |
Why?
| | Mice, Inbred CBA | 1 | 2015 | 57 | 0.030 |
Why?
| | Mitochondria | 1 | 2022 | 992 | 0.030 |
Why?
| | Neuregulin-1 | 1 | 2015 | 49 | 0.030 |
Why?
| | Electrophysiology | 1 | 2015 | 218 | 0.030 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2015 | 194 | 0.030 |
Why?
| | Cell Movement | 1 | 2019 | 959 | 0.030 |
Why?
| | Prospective Studies | 1 | 2026 | 8057 | 0.020 |
Why?
| | Spiral Ganglion | 1 | 2013 | 2 | 0.020 |
Why?
| | Developmental Biology | 1 | 2013 | 24 | 0.020 |
Why?
| | Transcription Factor Brn-3C | 1 | 2012 | 1 | 0.020 |
Why?
| | Stereocilia | 1 | 2012 | 9 | 0.020 |
Why?
| | Genes, Lethal | 1 | 2012 | 30 | 0.020 |
Why?
| | Gene Knock-In Techniques | 1 | 2012 | 61 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2013 | 407 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2012 | 196 | 0.020 |
Why?
| | Myosins | 1 | 2012 | 132 | 0.020 |
Why?
| | Organogenesis | 1 | 2012 | 63 | 0.020 |
Why?
| | Fibroblast Growth Factor 10 | 1 | 2010 | 23 | 0.020 |
Why?
| | GATA3 Transcription Factor | 1 | 2010 | 22 | 0.020 |
Why?
| | Zebrafish | 1 | 2015 | 532 | 0.020 |
Why?
| | Mechanotransduction, Cellular | 1 | 2012 | 121 | 0.020 |
Why?
| | Risk Factors | 1 | 2025 | 10885 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2012 | 891 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 3116 | 0.020 |
Why?
| | Phylogeny | 1 | 2013 | 917 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2012 | 429 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 2012 | 523 | 0.020 |
Why?
| | Adult Stem Cells | 1 | 2008 | 40 | 0.020 |
Why?
| | Alleles | 1 | 2010 | 894 | 0.020 |
Why?
| | Ethics, Medical | 1 | 2008 | 90 | 0.020 |
Why?
| | Embryonic Stem Cells | 1 | 2008 | 124 | 0.020 |
Why?
| | Pluripotent Stem Cells | 1 | 2008 | 82 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2012 | 2188 | 0.020 |
Why?
| | Cochlear Implants | 1 | 2008 | 96 | 0.020 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 1189 | 0.010 |
Why?
| | Aged | 1 | 2026 | 26153 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2012 | 4148 | 0.010 |
Why?
| | Middle Aged | 1 | 2026 | 36215 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2022 | 17291 | 0.010 |
Why?
| | Lung Neoplasms | 1 | 2015 | 2664 | 0.010 |
Why?
| | Pregnancy | 1 | 2012 | 7202 | 0.010 |
Why?
|
|
Kopecky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|